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ARTICLE
A group approach to genetic counselling of
cardiomyopathy patients: satisfaction and
psychological outcomes sufficient for further
implementation
Ellen Otten*,1, Erwin Birnie1, Adelita V Ranchor2, J Peter van Tintelen1 and Irene M van Langen1
The introduction of next-generation sequencing in everyday clinical genetics practise is increasing the number of genetic
disorders that can be confirmed at DNA-level, and consequently increases the possibilities for cascade screening. This leads
to a greater need for genetic counselling, whereas the number of professionals available to provide this is limited. We therefore
piloted group genetic counselling for symptomatic cardiomyopathy patients at regional hospitals, to assess whether this could be
an acceptable alternative to individual counselling. We performed a cohort study with pre- and post-counselling patient
measurements using questionnaires, supplemented with evaluations of the group counselling format by the professionals
involved. Patients from eight regional hospitals in the northern part of the Netherlands were included. Questionnaires comprised
patient characteristics, psychological measures (personal perceived control (PPC), state and trait anxiety inventory (STAI)), and
satisfaction with counsellors, counselling content and design. In total, 82 patients (mean age 57.5 year) attended one of 13
group sessions. Median PPC and STAI scores showed significantly higher control and lower anxiety after the counselling. Patients
reported they were satisfied with the counsellors, and almost 75% of patients were satisfied with the group counselling. Regional
professionals were also, overall, satisfied with the group sessions. The genetics professionals were less satisfied, mainly because
of their perceived large time investment and less-than-expected group interaction. Hence, a group approach to cardiogenetic
counselling is feasible, accessible, and psychologically effective, and could be one possible approach to counselling the
increasing patient numbers in cardiogenetics.
European Journal of Human Genetics (2015) 23, 1462–1467; doi:10.1038/ejhg.2015.10; published online 4 February 2015
INTRODUCTION
With the introduction of next-generation sequencing (NGS) in
everyday clinical genetics practise, the number of genetic disorders
that can be confirmed at DNA-level increases. This leads to a greater
need for genetic counselling and testing of index patients and their
close relatives, through cascade screening. However, the number of
genetic professionals available cannot increase at the same rate, and
other health professionals are generally insufficiently equipped for this
task. This imbalance demands us to find new ways to effectively and
efficiently accommodate to both the current and anticipated increase
in requests for genetic counselling and testing, while maintaining the
current levels of quality of care and patient satisfaction. This applies
particularly to patients with relatively prevalent diseases, like cardio-
myopathies, in which preventive options lead to a decrease in
morbidity and mortality.
Hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy
(DCM) are two common subtypes of cardiomyopathy. Prevalences are
about 1:500 for HCM and the same or higher for DCM.1,2 Most HCM
cases are familial, with (probable) causative genetic variants being
found in up to 60% of familial and in ~ 30% of sporadic cases, using
traditional sequencing techniques.3 In a Dutch cohort, the overall yield
for familial and sporadic cases was 46%.4 About one-third of DCM
cases are familial and a genetic cause can be found in 30–50% of these
families.5,6 Familial cardiomyopathy mostly has an autosomal domi-
nant mode of inheritance with reduced penetrance and variable
expression, and preventive and treatment options are available. This
makes cascade genetic testing of family members recommended
practise.3 Because NGS further increases the yield of causative genetic
variants found in index patients, the number of family members being
referred for genetic counselling and testing will also increase.
Group counselling is an attractive way of handling this increasing
flow of patients to clinical genetics departments. It has been
introduced in several medical disciplines,7 with the aim of providing
information, patients sharing personal experiences, and increasing the
efficiency of counselling for professionals. The general goals of genetic
counselling are to increase patients’ knowledge about their disease and
its genetic aspects, and to ensure that patients can control their feelings
about their situation/condition, resulting in the ability to make
autonomous choices for themselves and their relatives. This is usually
done in individual sessions, but could also be achieved group-wise as
has been confirmed by experiences with breast cancer group
counselling.8–11 These studies confirm that the aims and expected
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advantages of group counselling can be reached.10 Patient satisfaction
and the psychological outcomes of group genetic counselling are
also generally positive.8–10 This oncogenetic group counselling
mainly includes small heterogeneous patient groups that include
both symptomatic and risk carriers. As far as we are aware, group
counselling has not been piloted in cardiogenetics, despite being a
rapidly growing segment of referrals.
We therefore piloted group genetic counselling for symptomatic
cardiomyopathy patients as part of an intervention to increase access
to genetic counselling and testing for patients and cardiologists at
small regional hospitals in our service area. Our aim was to deliver
adequate quality of care through group counselling. First, we wanted
to determine whether the psychological benefits of group counselling
were adequate, and at least comparable to the benefits of individual
counselling. Second, we investigated both patients’ and medical
professionals’ satisfaction with this type of counselling.
METHODS
Study design and patients
This was a cohort study with pre- and post-counselling measurements,
conducted in eight small regional hospitals (mean 326 beds; range 197–642)
in the northern part of the Netherlands (total area about 8304 km2 with about
1.7 million inhabitants). HCM and DCM index patients who had not attended
genetic counselling and testing before, or those who felt the need for a second
counselling, were eligible to participate. Thirteen group sessions took place
between March 2011 and November 2012.
Study process
In the Netherlands, genetic counselling and testing for cardiomyopathies are
performed by clinical geneticists and genetic counsellors employed at eight
university medical centers (UMCs), in collaboration with psychosocial workers
and dedicated cardiologists. This care is covered by compulsory, Dutch health
insurance general policies. Cardiologists in nine regional hospitals within the
service area of our university hospital were informed of the possibility of
organising group counselling sessions in their hospital, and the formal referral
criteria for genetic counselling and testing for symptomatic HCM and DCM
patients were brought to their attention.12,13 Eight out of nine hospitals decided
to participate.
Participating cardiologists and heart failure nurses selected eligible patients
and informed them about the possibility of group genetic counselling.
Interested patients received a standardized information letter about the possible
genetic character of their cardiomyopathy and about the option for group
genetic counselling and testing. Individual genetic counselling in the university
hospital or at one of our three regular regional outpatient clinics was offered as
an alternative. An application form, information-leaflet on group counselling
and a stamped return-envelope were added. Patients who applied received an
invitation. The preparations for group counselling were similar to those for
standard individual care.
The counselling sessions were held in the afternoon or evening, in meeting
rooms in the participating hospitals. All patients could bring one relative/
partner. At the beginning of the session, each participant was asked to sign a
combined ‘confidence declaration’ and informed consent form to emphasise
the confidential nature of the setting. Sessions lasted ~ 2 h, including complet-
ing the research questionnaires (taking about 30min) and a break. The legal
department of our hospital approved the patient information material we
compiled and the group counselling format regarding informed consent and
privacy issues. Approval by a medical ethics committee was considered
unnecessary because this care modality is also used in regular care.
The counselling team consisted of four professionals: (1) a clinical geneticist-
in-training provided the regular cardiogenetic and pre-test information,
including a PowerPoint presentation, to patients and answered genetic
questions, (2) a social worker was group leader and focused on group
interactions and psychosocial issues of patients, (3) a local cardiologist and/or
heart failure nurse was present to answer specific cardiological questions, and
(4) a clinical geneticist was present to supervise and assist with the short
individual discussions after the group session had ended. These took about
5–10min per patient and comprised recording additional personal and family
history and discussion of personal considerations in DNA-testing. Immediately
after the sessions, blood withdrawal for diagnostic DNA-testing was offered to
all patients and performed in those who consented.
Group sessions differed from our standard individual counselling in three
respects: (1) groups of unrelated patients were counselled together instead of
individually, (2) counselling was done by a team instead of a single counsellor
assisted by a social worker or cardiologist when necessary, and (3) counselling
was given in the regional hospitals instead of at our department or regular
outpatient clinics.
Patient measurements
The questionnaires before and immediately after the group counselling session
requested the following information.
Patient characteristics. Patient’s age, sex, number of offspring, educational
level, diagnosis, and age at diagnosis.
Referral for genetic counselling. Patients were asked (1) who initiated their
referral for genetic counselling and (2) if they had previously discussed referral
for genetic counselling with their cardiologist.
Patient’s questions. Before the group session began, patients were asked to
indicate which questions they wanted to have answered during the session and
if they had any additional questions that they preferred not to have discussed in
the group. Afterwards, patients were asked which of their questions had been
answered and which not, and if they had heard any information during the
session that they would have preferred not to know.
We included five measures in the questionnaires to assess the experienced
quality and the psychological outcomes of the counselling sessions in our
patients:
Personal perceived control. The validated nine-item PPC (Dutch version) was
used to measure patient’s perceived control before and after genetic counselling
(α= 0.79–0.81).14 The response mode is a 0–2 Likert scale. Higher scores
indicate higher levels of perceived control.
State and trait anxiety inventory. The Dutch six-item short version of the STAI
was used to measure patient’s experienced anxiety before and after genetic
counselling. The response mode is a 1–4 Likert scale, with higher scores
indicating higher levels of anxiety. The convergent validity of the Dutch version
of the STAI-6 with the full STAI showed a correlation of 0.95.15,16
Clinical genetics satisfaction indicator (CGS). This seven-item questionnaire
was adopted by the Clinical Genetics Association in the Netherlands to measure
patient satisfaction with genetic counselling. The response mode is a 1–5 Likert
scale. Higher scores indicate higher satisfaction. The English version shows
excellent internal consistency in a clinical genetics setting (α= 0.91).17 Internal
consistency in the present study was 0.80.
Patient preferences. Before the group counselling session, patients were asked
to indicate their preference for the three main characteristics of group and
individual counselling: (1) counselling in their local hospital versus counselling
in the university hospital, (2) counselling by a team (geneticist, social worker
and cardiologist) or by a single genetic counsellor, and (3) counselling in a
group versus individually. They were also asked to indicate their overall
preference for either group or individual counselling based on the three aspects
jointly. The five-point response mode ranged from ‘definite preference for
group counselling’ to ‘no preference’ to ‘definite preference for individual
counselling’.
Evaluation of content and design. Content was defined as both the appreciation
of individual parts of the counselling and of the information given. Design
concerned: (1) the appreciation of the entire process from referral to
counselling, and (2) the composition of the group session itself and the
presence of fellow patients. These were evaluated by means of a 20-item ad hoc
questionnaire, using a 0–2 Likert scale (totally agree/partly agree/disagree) as
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response mode. Higher scores indicated higher satisfaction with content and/or
design of the group session. ‘Being satisfied’ was defined as ‘sum-scores’
≥ 80/100.
Professionals’ opinions
At the end of the pilot period, all the professionals involved from the regional
hospitals were sent an online questionnaire to evaluate the group sessions in
terms of (1) their positive and negative experiences with the group sessions,
(2) any feedback from patients, (3) suggestions for improvement, (4) willingness
to organise further group sessions, and (5) willingness to refer patients to our
university hospital for group counselling. We also asked them to rate their
overall satisfaction with the group counselling session (1= very unsatisfied to
10= very satisfied). The social worker, clinical geneticist, and clinical geneticist-
in-training evaluated the group counselling approach informally after each
session, and more extensively at the end of the pilot period. Evaluation included
feasibility and course of the sessions, interaction during the sessions, and their
additional positive and negative experiences.
Analysis
The descriptive statistics used in this study were mean (SD) for variables with
normal distributions, median (interquartile range) for variables with skewed
distributions, and n(%) for nominal and ordinal variables. PPC, STAI, and GCS
outcomes were analysed for patients who completed at least two-third of these
questionnaires. Mean item scores per patient were calculated. Changes of PPC
and STAI scores within patients were tested using the Wilcoxon rank-sum test
for skewed variables and the paired Student’s t-test for changes with normal
distributions. We used the same tests to compare differences in PPC, STAI and
CGS outcomes between small and large counselling groups (o7 versus ≥ 7
patients). Estimated effect sizes were added. Data were analysed using SPSS
statistics v20 (IBM Corporation, New York, NY, USA).
RESULTS
Study process and sample
During the study, 121 of the selected/approached patients were invited
for a group counselling session (maximum ~80%; the exact number
of patients selected/approached is unknown, as this was not fully
reported by all cardiologists). Of those invited, 82 patients (68%)
attended one of the sessions, with 61 accompanying relatives/partners
(Figure 1). Reasons for the 30 patients not attending their scheduled
session ranged from not being interested in genetic counselling and
testing on second thought (n= 4; 13%) to more practical reasons
(n= 17; 57%; eg, sickness, having no transport, having other obliga-
tions at the time of the session), or simply not showing up for
unknown reasons (n= 9; 30%). Median age of patients not showing
up was 59.5 years (range 30–78), of whom 40% were male and 73%
were referred because of DCM. The median age and proportion of
DCM of these patients were comparable to the joining patients,
whereas the no show-group did contain more females than the
patients attending a group session. Median size of the group sessions
was six patients (range 3–13 patients), and nine participants including
accompanying relatives (range 5–27 persons). Four patients eventually
attended an individual session at the university hospital instead of a
group session; all because they were unable to be present at the
scheduled group session and chose to attend the UMC for an
individual session at short-term rather than waiting for a next group
session at their own hospital. Patient characteristics are shown in
Table 1. In total, 75 of 82 patients (91%) completed both sets of
questionnaires before and after the counselling session, whereas 81 of
82 patients completed at least one set. At the end of the pilot period,
four cardiologists and two heart failure nurses from five of eight
cooperating hospitals completed the professionals’ evaluations.
Patient measurements
Referral for genetic counselling. Thirteen patients (16%) reported
having discussed genetic counselling with their doctor previously,
but they did not attend/were not referred for genetic counselling until
group genetic counselling was offered in their regional hospital. Three
patients had been previously counselled individually at our university
hospital and had DNA-testing initiated, but nevertheless wished to
attend additional group genetic counselling.
Figure 1 Overview of patients invited for a group counselling session. Legend: ‘unfairly’=patients suspected of having a heritable cardiac disease, but not
fulfilling the formal criteria for joining a group counselling session; ‘fairly’=patients fulfilling the formal criteria for joining a group counselling session.
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Patient questions. Forty-two patients (51%) reported at least one
question they wished to have answered. Most questions addressed the
consequences of confirming heritability for the patient and his/her
close family members (n= 22 questions; 35% of questions) and
cardiologic signs, symptoms and complaints (n= 17; 27% of ques-
tions). At the start of the session, one patient reported one topic, her
personal situation, which she did not want to discuss during the group
session. Afterwards, five patients reported having received general
answers to their questions, but no specific answers for their personal
situation. Only one patient reported having heard information he/she
would have preferred not to know; this concerned the possibility/risk
of sudden cardiac death in cardiomyopathy.
Psychological and satisfaction outcomes. Median change scores of the
PPC were significantly higher (increased control) and those of the
STAI were significantly lower (less anxiety) after counselling for all
groups in relation to before the session (related samples Wilcoxon test,
Po0.001 for both; Table 2), with effect sizes of 1.00 and 0.49,
respectively (Table 2). Patients also reported they were satisfied with
the counsellors (Table 2); 56.5% of patients gave the maximum CGS
questionnaire score of 5.0. PPC and STAI change scores and CGS
scores did not differ significantly between small and large counselling
groups (Independent Mann–Whitney U-test, P= 0.74, P= 0.94, and
P= 0.31, respectively; Table 2). The majority of patients indicated that
they would join a group counselling session again if genetic counsel-
ling would be necessary (87.7%), and would recommend it to family
members (81.4%).
Patient preferences. When comparing each main characteristic of our
group counselling approach to its corresponding aspect in our
individual counselling practise separately, almost half of the patients
(48.5%) preferred their local hospital over the university hospital,
whereas 40% did not have any preference.
Regarding the involved professionals in each type of counselling,
52% did not have any preference for counselling by the multi-
disciplinary team or for counselling by just a single counsellor.
When taking all main characteristics of both counselling types into
account, one-fourth of our patients preferred group counselling
overall, whereas 30% preferred individual counselling overall.
The remaining patients (45.3%) did not have a clear overall preference
for one of both counselling types.
Evaluation of content and design. Almost three-quarters of our
patients reported being satisfied with the content (74.3%) and design
(73.4%) of the group counselling session (Figure 2). One patient
reported the design of the group session process being overall
insufficient (score 41 of 100). The items with mean lowest success
scores in all patients (range 1–5) were ‘usefulness of discussing DNA-
testing with fellow patients’ (mean score 1.26) and ‘experiencing
support from fellow patients’ (mean score 1.11).
Professionals’ evaluations. Regional professionals reported they were
satisfied overall with the course of the group counselling at their
hospital (mean score 7.8). No negative reactions from their patients
were reported. Suggestions for improvement were to be clearer about
the session aims (emphasis on genetic information, not on cardiac
information), to shorten its duration (shorter introduction), and to
consider optimal group size (maximum 10 patients) and time of day
(symptomatic patients may be too tired by the end of the day).
Table 1 Characteristics of all patients attending group counselling
sessions
Characteristic
Age (yr); median (range) 57.5 (20–79)
Sex; number male/female (%) 45/37 (55/45%)
Patients with offspring (% yes) 71 (89%)
Educational level









Time since diagnosis (yr); median (range)a 2.0 (0–25)
Abbreviations: DCM=dilated cardiomyopathy; HCM=hypertrophic cardiomyopathy; yr= year.
an=2 unknown.
















PPC n 64 34 30
Before 0.89 (0.44) 0.89 (0.44) 0.78 (0.50)
After 1.24 (0.56) 1.39 (0.47) 1.17 (0.44)
Δ 0.33 (0.44) 0.41 (0.42)a 0.30 (0.47)a
STAI n 67 36 31
Before 1.67 (0.67) 1.83 (0.67) 1.67 (0.70)
After 1.67 (0.83) 1.67 (0.63) 1.50 (1.17)
Δ 0.17 (0.33) 0.08 (0.50) 0.17 (0.33)
CGS n 69 37 32
After 5.0 (0.50) 5.0 (0.29) 5.0 (0.71)
Abbreviations: After= immediately after session; Before= at start of session; CGS= clinical
genetics satisfaction indicator; IQR= interquartile range; STAI= state and trait anxiety inventory;
Δ= change between before and after; n=number of patients; PPC=personal perceived control















Figure 2 Patient satisfaction with content and design of group counselling
sessions.
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All professionals indicated they were willing to organise group
counselling sessions for index patients in the future. One of six
professionals was not willing to refer patients to the university hospital
for group counselling because she thought the regional group concept
is more suitable for increasing access to genetic counselling.
The genetics professionals involved were less enthusiastic about the
group counselling format than their regional cardiologic colleagues:
one positive aspect mentioned was that more, and possibly different,
patients were reached and informed by this new approach. Perceived
disadvantages were that group counselling in eight hospitals was less
efficient than counselling at the university hospital (mainly due to
travelling time), that the practical organisation of the sessions was
difficult and time-consuming, and that it was sometimes difficult to
stimulate the group interaction.
DISCUSSION
We evaluated the quality and satisfaction of group genetic counselling
for symptomatic cardiomyopathy patients. The outcomes show that
the group counselling participants experienced good quality of care,
that group counselling was not harmful, and that the psychological
aims were met. Moreover, the professionals involved from the regional
hospitals were overall positive about this way of providing genetic
counselling. Finally, our group counselling approach seemed feasible,
acceptable, and satisfied a need in the view of the number of patients
that attended group counselling.
As far as we know, we are the first to have piloted and evaluated
group counselling in cardiogenetic patients. We included a substantial
number of patients to support the reliability of our results. The
participants were heterogeneous in terms of gender, age, and educa-
tional level, which suggests that, overall, group counselling is
acceptable to a wide range of patients. Finally, our pilot study closely
mimicked daily practise, that is, the barriers we faced probably also
occur in daily practise. This makes our group approach relatively easy
being integrated in existing clinical workflow (Figure 3).
Reference PPC and STAI data for cardiomyopathy patients are
unavailable. The psychological outcomes of our patients showed
suboptimal baseline as well as post-counselling levels of PPC scores,
and better STAI scores than reports on individually counselled
oncogenetic patients in the Netherlands. However, the improvements
in scores between pre- and post-counselling (within patients) were
similar.9,14,8–20 Our PPC results in cardiogenetics are also comparable
to group counselling in oncogenetics,9 and several reports from the
United Kingdom about STAI outcomes in oncogenetics show similar
improvements in scores as in our patients.21–23 The psychological
outcomes of our patients may have been influenced by group size,
group dynamics, and/or the management of questions which they did
or did not want to be addressed during the group session. But this all
seems unlikely as the psychological outcomes of both the smaller and
larger groups in our study were about equal (Table 2). Only one
patient indicated a topic she preferred not to be discussed and only
one patient reported having heard some information he would have
preferred not to know. This leads us to conclude that our patients
overall accept group counselling psychologically and are not
harmed by it.
In addition to the positive outcomes of group counselling reported
by the patients and the regional professionals, our approach had some
indirect effects. By bringing genetic counselling closer to our patients
and the regional professionals, we lowered the threshold for attending
genetic counselling, and we provided education and created awareness
in the regional professionals, which hopefully will have an ongoing
beneficial effect on their referral rates.
Unlike the patients and the regional professionals, the genetics
professionals experienced several drawbacks with group counselling,
particularly a greater time investment and less interaction among
patients than expected. Additional research is needed, with regard to
time investment, to determine the most appropriate format of the
group counselling sessions for both the patients and professionals
involved. Sessions could be adapted regarding design, duration, and/or
location, to meet the requirements of both patients and professionals.
Regarding patient interactions, our expectations were perhaps too
much influenced by the literature on repeated group sessions, for
example, in diabetic care.7,24 A minimum level of group bonding is
needed before patients will share thoughts and experiences: this is
more likely to evolve over the course of multiple sessions. Moreover,
the limited group interaction might also be partly due to the fact that
most of these symptomatic patients had already decided for genetic
testing before attending the group session, making group interaction
less important for them. However, the patient outcomes for the
counselling sessions did not suffer from the limited interaction, as
shown by the PPC and STAI results. The degree of interaction might
be different in group counselling of relatives considering predictive
testing, but this has yet to be investigated.
Figure 3 Flow chart – integration of the group genetic counselling process into routine care.
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One study limitation is that we cannot be certain that our results are
unbiased, owing to the absence of a matched control group that
received individual counselling. Moreover, PPC and STAI changes
were evaluated directly after the counselling sessions and we did not
evaluate the persistence of these benefits in the longer term. Our
results may also have been subject to participation bias, as the patients
chose to join group counselling rather than refusing this type of
counselling outright.
In conclusion, in the near future results of NGS diagnostics will
become available for large numbers of HCM and DCM patients, and
for patients with other (common) genetic diseases. Because of this
anticipated increase, together with growing awareness of these growing
possibilities, we should be prepared for an increased demand for
genetic counselling and testing of patients and their family members.
Fulfilling these needs is important in the light of achieving health
gains. Our results support our hypothesis that group genetic counsel-
ling in cardiogenetics is a feasible, accessible, and psychologically
effective way of counselling large numbers of symptomatic cardiomyo-
pathy patients. Further research is needed to determine which type of
counselling will be most suitable in view of increasing patient
numbers, thereby satisfying both patients’ and professionals’ needs,
maintaining at least current levels of quality and of access to clinical
genetic care, and being cost-effective.
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